Health Canada — Medical Devices · Canada · 2018-11-02 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Maquet/Getinge has received complaints involving the Cardiosave IABPs regarding the use of certain Intra-Aortic Balloons (IABs) at altitudes above 975 Meters. The Cardiosave may not successfully complete the autofill process required to initiate pumping. This failure may result in either interruption of therapy upon the first maintenance autofill or the inability to start therapy. This condition could potentially lead to patient hemodynamic instability. There have been no adverse events or deaths attributed to this issue. IABs used with the CS100 or CS300IAPB are not affected by the issue.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.